Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (181-190 of 450) with videos related to

Pageof 45
Sort By:
Acta Neuropathologica|November 16, 2019
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutationPhilipp Sievers, Daniel Schrimpf, Damian Stichel, et al.
Neuro-Oncology|August 30, 2024
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.
Acta Neuropathologica Communications|February 4, 2021
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activationAndrey Korshunov, Konstantin Okonechnikov, Felix Schmitt-Hoffner, et al.
Oncotarget|October 6, 2017
Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose fluxElena I Ilina, Angela Armento, Leticia Garea Sanchez, et al.
Neuro-Oncology|May 8, 2018
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 TDaniel Paech, Johannes Windschuh, Johanna Oberhollenzer, et al.
Neuro-Oncology Advances|July 10, 2020
Highlights of the inaugural ten - the launch of Neuro-Oncology AdvancesFarshad Nassiri, Kenneth Aldape, Manmeet Alhuwalia, et al.
Neuro-Oncology|February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningiomaFranziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
Acta Neuropathologica|October 23, 2023
PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumorsArnault Tauziède-Espariat, Aurore Siegfried, Yvan Nicaise, et al.
Neuro-Oncology|January 17, 2019
Molecular and translational advances in meningiomasSuganth Suppiah, Farshad Nassiri, Wenya Linda Bi, et al.
Scientific Reports|January 25, 2017
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosisTobias V Lanz, Sarah K Williams, Aleksandar Stojic, et al.
Pageof 45

Showing results (181-190 of 450) with videos related to

Sort By:
Pageof 45
Acta Neuropathologica|November 16, 2019
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutationPhilipp Sievers, Daniel Schrimpf, Damian Stichel, et al.
Neuro-Oncology|August 30, 2024
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.
Acta Neuropathologica Communications|February 4, 2021
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activationAndrey Korshunov, Konstantin Okonechnikov, Felix Schmitt-Hoffner, et al.
Oncotarget|October 6, 2017
Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose fluxElena I Ilina, Angela Armento, Leticia Garea Sanchez, et al.
Neuro-Oncology|May 8, 2018
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 TDaniel Paech, Johannes Windschuh, Johanna Oberhollenzer, et al.
Neuro-Oncology Advances|July 10, 2020
Highlights of the inaugural ten - the launch of Neuro-Oncology AdvancesFarshad Nassiri, Kenneth Aldape, Manmeet Alhuwalia, et al.
Neuro-Oncology|February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningiomaFranziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
Acta Neuropathologica|October 23, 2023
PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumorsArnault Tauziède-Espariat, Aurore Siegfried, Yvan Nicaise, et al.
Neuro-Oncology|January 17, 2019
Molecular and translational advances in meningiomasSuganth Suppiah, Farshad Nassiri, Wenya Linda Bi, et al.
Scientific Reports|January 25, 2017
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosisTobias V Lanz, Sarah K Williams, Aleksandar Stojic, et al.
Pageof 45